Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
Abstract The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many proces...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-21851-8 |
_version_ | 1798028594101878784 |
---|---|
author | Sabina Galiniak Rafał Podgórski Marta Rachel Artur Mazur |
author_facet | Sabina Galiniak Rafał Podgórski Marta Rachel Artur Mazur |
author_sort | Sabina Galiniak |
collection | DOAJ |
description | Abstract The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF. |
first_indexed | 2024-04-11T19:10:33Z |
format | Article |
id | doaj.art-391ed9695c4e4e33a865a9c61c864bb0 |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-04-11T19:10:33Z |
publishDate | 2022-10-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-391ed9695c4e4e33a865a9c61c864bb02022-12-22T04:07:37ZengNature PortfolioScientific Reports2045-23222022-10-011211810.1038/s41598-022-21851-8Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single studySabina Galiniak0Rafał Podgórski1Marta Rachel2Artur Mazur3Institute of Medical Sciences, Medical College, Rzeszów UniversityInstitute of Medical Sciences, Medical College, Rzeszów UniversityInstitute of Medical Sciences, Medical College, Rzeszów UniversityInstitute of Medical Sciences, Medical College, Rzeszów UniversityAbstract The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF.https://doi.org/10.1038/s41598-022-21851-8 |
spellingShingle | Sabina Galiniak Rafał Podgórski Marta Rachel Artur Mazur Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study Scientific Reports |
title | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_full | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_fullStr | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_full_unstemmed | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_short | Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study |
title_sort | serum kisspeptin and proopiomelanocortin in cystic fibrosis a single study |
url | https://doi.org/10.1038/s41598-022-21851-8 |
work_keys_str_mv | AT sabinagaliniak serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy AT rafałpodgorski serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy AT martarachel serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy AT arturmazur serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy |